BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23601902)

  • 1. Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases.
    Manceau G; Brouquet A; Bachet JB; Penna C; El Hajjam M; Rougier P; Nordlinger B; Benoist S
    Surgery; 2013 Sep; 154(3):528-35. PubMed ID: 23601902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases.
    Ayez N; Burger JW; van der Pool AE; Eggermont AM; Grunhagen DJ; de Wilt JH; Verhoef C
    Dis Colon Rectum; 2013 Mar; 56(3):281-7. PubMed ID: 23392140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.
    Martijnse IS; Dudink RL; Kusters M; Vermeer TA; West NP; Nieuwenhuijzen GA; van Lijnschoten I; Martijn H; Creemers GJ; Lemmens VE; van de Velde CJ; Sebag-Montefiore D; Glynne-Jones R; Quirke P; Rutten HJ
    Ann Surg Oncol; 2012 Feb; 19(2):392-401. PubMed ID: 21792506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.
    An HJ; Yu CS; Yun SC; Kang BW; Hong YS; Lee JL; Ryu MH; Chang HM; Park JH; Kim JH; Kang YK; Kim JC; Kim TW
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):73-80. PubMed ID: 22300562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone.
    Schroeder C; Gani C; Lamprecht U; von Weyhern CH; Weinmann M; Bamberg M; Berger B
    Int J Hyperthermia; 2012; 28(8):707-14. PubMed ID: 23006132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection of liver metastases from colo-rectal cancers.
    Nordlinger B; Quilichini MA; Parc R; Hannoun L; Delva E; Huguet C
    Int Surg; 1987; 72(2):70-2. PubMed ID: 3301715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rectal cancer: current status of multimodal therapy--when and how?].
    Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
    Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Brain Metastasis from Rectal Cancer with Synchronous Liver and Lung Metastases after Multimodality Treatment--A Case Report].
    Udagawa M; Tominaga B; Kobayashi D; Ishikawa Y; Watanabe S; Adikrisna R; Okamoto H; Yabata E
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1608-10. PubMed ID: 26805112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases.
    Hatwell C; Bretagnol F; Farges O; Belghiti J; Panis Y
    Colorectal Dis; 2013 Jan; 15(1):e21-8. PubMed ID: 23088162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical results from chemoradiation with 5-fluorouracil and oxaliplatin for locally advanced rectal cancer.
    Lawson JD; Kauh J; Koshy M; Staley C; Landry J
    Clin Colorectal Cancer; 2008 Sep; 7(5):325-30. PubMed ID: 18794065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
    Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
    Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
    Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases.
    van der Pool AE; de Wilt JH; Lalmahomed ZS; Eggermont AM; Ijzermans JN; Verhoef C
    Br J Surg; 2010 Mar; 97(3):383-90. PubMed ID: 20101594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer.
    Coco C; Valentini V; Manno A; Mattana C; Verbo A; Cellini N; Gambacorta MA; Covino M; Mantini G; Miccichè F; Pedretti G; Petito L; Rizzo G; Cosimelli M; Impiombato FA; Picciocchi A
    Dis Colon Rectum; 2006 Mar; 49(3):311-8. PubMed ID: 16456636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.
    Chiappa A; Bertani E; Makuuchi M; Zbar AP; Contino G; Viale G; Pruneri G; Bellomi M; Della Vigna P; Zampino MG; Fazio N; Travaini ML; Trifirò G; Corbellini C; Andreoni B
    Hepatogastroenterology; 2009; 56(91-92):829-34. PubMed ID: 19621711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.